Leptospirosis is a globally important zoonotic disease that affects humans
on all continents, in both urban and rural contexts, and in temperate and t
ropical climes. Leptospirosis is a disease of the environment; transmission
depends on interactions between humans and mammalian reservoir hosts. A va
riety of infectious diseases that present as undifferentiated febrile syndr
omes, such as malaria, dengue and influenza, as well as viral hemorrhagic f
evers can mimic leptospirosis. The importance of pulmonary hemorrhage as a
lethal complication of leptospirosis has become more widely recognized. In
contrast to textbook dogma, population-based studies indicate that there is
a poor correlation between infecting leptospiral strain and clinical expre
ssion of disease. Genetic transformation of a Leptospira sp. has now been r
eported, which should allow for detailed analysis of a variety of leptospir
al genes. Publication of the whole Leptospira genome is eagerly awaited. Fo
llowing recent reports of a new, highly effective conjugate typhoid vaccine
, new efforts to find leptospirosis vaccines should include the manufacture
and testing of conjugate leptospiral lipopolysaccharide vaccines. Recent a
dvances, particularly in epidemiology, molecular genetics and pathogenesis,
are placing leptospirosis at the cutting edge of biomedical science. Curr
Opin Infect Dis 14:527-538. (C), 2001 Lippincott Williams & Wilkins.